Downloads

Feature

What makes a good drug target?


Stephen Carney

In this article, Isabella Gashaw , Peter Ellinghaus, Anette Sommer and Khusru Asadullah discuss those factors that differentiate good drug targets from poor or the unusable.

Novel therapeutics in areas with a high unmet medical need are based on innovative drug targets. Although ‘biologicals’ have enlarged the space of druggable molecules, the number of appropriate drug targets is still limited. Discovering and assessing the potential therapeutic benefit of a drug target is based not only on experimental, mechanistic and pharmacological studies but also on a theoretical molecular druggability assessment, an early evaluation of potential side effects and considerations regarding opportunities for commercialization. This article defines key properties of a good drug target from the perspective of a pharmaceutical company.

Share this article

More services

 

This article is featured in:
Pharmacology/ Therapeutics

 

Comment on this article

You must be registered and logged in to leave a comment about this article.